ILIAS Biologics, Inc.
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Holding
- Established
- 2015-11-02
- Employees
- 51
- Market Cap
- -
- Website
- http://www.iliasbio.com
A Study to Evaluate the Safety and Tolerability of ILB-202
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2025-03-07
- Lead Sponsor
- ILIAS Biologics Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT05843799
- Locations
- 🇦🇺
Adelaide, Adelaide, Australia
© Copyright 2025. All Rights Reserved by MedPath